Sort
21,453 grants matching “tuberculosis”
Tuberculosis Elimination and Laboratory Cooperative Agreements
$647,310Harvey L Marx · Missouri State Dept/ Health & Senior Srv · U52 · FY2011 · PS
National Resource For Advanced NMR Technology
$647,247Timothy A Cross · Florida State University · P41 · FY2018 · GM
Clinical Suspicion of TB: A Technology Assessment Tool
$647,226University Of California San Diego · R01 · FY2004 · AI
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
$647,179David Crich · Wayne State University · R01 · FY2017 · AI
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
$647,023Sheela Shenoi · Yale University · R01 · FY2021 · DA
Development of novel anti-TB drugs that inhibit cell wall biosynthesis and respiration
$647,019David Alland · Hackensack University Medical Center · U19 · FY2020 · AI
Evaluation of a novel breath sensor for rapid, low-cost diagnosis of tuberculosis in children
$646,982Midori Kato-Maeda · University Of California, San Francisco · R01 · FY2021 · HL
Role of mycobacterial dynamin-like proteins in the biogenesis of membrane vesicles, and host-pathogen interactions
$646,940Gloria Marcela Rodriguez · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
The impact of alcohol consumption on TB treatment outcomes
$646,900Karen R Jacobson · Boston Medical Center · R01 · FY2019 · AI
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$646,826Douglas K Owens · Stanford University · R01 · FY2014 · DA
HIV/TB in Uganda: Punctuated Antiretroviral Therapy
$646,764Christopher C. Whalen · University Of Georgia · R01 · FY2007 · AI
Safe Pregnancy by Infectious Disease Control in Kinshasa
$646,575University Of North Carolina Chapel Hill · U01 · FY2004 · HD
Defining how the spectrum of latency affects reactivation of TB
$646,562Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
$646,561John Lucian Davis · Yale University · R01 · FY2024 · HL
Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia
$646,445Heather L Wipfli · University Of Southern California · U01 · FY2023 · CA
Macaque T cell signatures of Mtb control
$646,350Francois J Villinger · Emory University · U19 · FY2015 · AI
Mechanism Based Inhibition of M Tuberculosis Enzymes
$646,225John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2012 · AI
High content screening of Mycobacterium tuberculosis
$646,203Tanya Parish · Access To Advanced Health Institute · R01 · FY2017 · AI
Advancing innovative therapies against pandrug-resistant Gram-negative superbugs
$646,188Qi Zhou · Purdue University · R01 · FY2023 · AI
PK/PD Evaluation Resistance Development in Caseating Granuloma
$646,181William Ramses Bishai · Johns Hopkins University · R01 · FY2011 · AI
Advancing innovative therapies against pandrug-resistant Gram-negative superbugs
$646,174Qi Zhou · Purdue University · R01 · FY2021 · AI
The impact of alcohol consumption on TB treatment outcomes
$646,074Karen R Jacobson · Boston Medical Center · R01 · FY2018 · AI
Innate Immune Control of TB and HIV
$646,050Anne Goldfeld · Boston Children'S Hospital · R56 · FY2021 · AI
Epidemiology of Mycobacterial Infections
$646,042D. Rebecca Prevots · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
PK/PD Evaluation Resistance Development in Caseating Granuloma
$645,971William Ramses Bishai · Johns Hopkins University · R01 · FY2010 · AI